NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Procaps Group, S.A. Ordinary Shares (NASDAQ: PROC)
PROC Technical Analysis
5
As on 21st Nov 2024 PROC STOCK Price closed @ 1.11 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.46 & Strong Sell for SHORT-TERM with Stoploss of 4.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PROCSTOCK Price
Open | 0.59 | Change | Price | % |
High | 1.13 | 1 Day | 0.58 | 109.43 |
Low | 0.59 | 1 Week | -0.44 | -28.39 |
Close | 1.11 | 1 Month | -1.13 | -50.45 |
Volume | 2514773 | 1 Year | -3.29 | -74.77 |
52 Week High 4.70 | 52 Week Low 0.61 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
NVDA | 146.67 | 0.53% |
AKTS | 0.10 | 11.11% |
WORX | 2.12 | 116.33% |
QUBT | 4.76 | 29.35% |
LMDX | 0.02 | 0.00% |
SMCI | 29.70 | 5.06% |
MSTR | 397.28 | -16.16% |
MARA | 23.81 | 22.17% |
CRNC | 5.83 | 106.74% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
PROC Daily Charts |
PROC Intraday Charts |
Whats New @ Bazaartrend |
PROC Free Analysis |
|
PROC Important Levels Intraday
RESISTANCE | 2.15 |
RESISTANCE | 1.82 |
RESISTANCE | 1.61 |
RESISTANCE | 1.40 |
SUPPORT | 0.82 |
SUPPORT | 0.61 |
SUPPORT | 0.40 |
SUPPORT | 0.07 |
PROC Forecast November 2024
4th UP Forecast | 2.29 |
3rd UP Forecast | 1.91 |
2nd UP Forecast | 1.68 |
1st UP Forecast | 1.44 |
1st DOWN Forecast | 0.78 |
2nd DOWN Forecast | 0.54 |
3rd DOWN Forecast | 0.31 |
4th DOWN Forecast | -0.07 |
PROC Weekly Forecast
4th UP Forecast | 1.63 |
3rd UP Forecast | 1.46 |
2nd UP Forecast | 1.36 |
1st UP Forecast | 1.26 |
1st DOWN Forecast | 0.96 |
2nd DOWN Forecast | 0.86 |
3rd DOWN Forecast | 0.76 |
4th DOWN Forecast | 0.59 |
PROC Forecast2024
4th UP Forecast | 9.69 |
3rd UP Forecast | 6.94 |
2nd UP Forecast | 5.24 |
1st UP Forecast | 3.54 |
1st DOWN Forecast | -1.32 |
2nd DOWN Forecast | -3.02 |
3rd DOWN Forecast | -4.72 |
4th DOWN Forecast | -7.47 |
Procaps Group, S.A. Ordinary Shares ( NASDAQ USA Symbol : PROC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PROC Other Details
Segment | EQ | |
Market Capital | 1090443904.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
PROC Address
PROC Latest News
PROC Business Profile
Procaps Group, S.A. operates as an integrated healthcare and pharmaceutical company worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately ten therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg City, Luxembourg. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service